Arcadia Biosciences (RKDA) Non-Current Deffered Revenue (2014 - 2017)

Arcadia Biosciences (RKDA) has 4 years of Non-Current Deffered Revenue data on file, last reported at $2.0 million in Q4 2017.

• Quarterly Non-Current Deffered Revenue fell 34.68% year-over-year to $2.0 million in Q4 2017, while the trailing twelve-month figure through Dec 2017 was $2.0 million (down 34.68% YoY) and the FY2017 annual result came in at $2.0 million, down 34.68% from the prior year.
• Non-Current Deffered Revenue fell to $2.0 million in Q4 2017, from $2.8 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $3.6 million in Q4 2014 to a low of $2.0 million in Q4 2017.
• A 4-year average of $2.8 million and a median of $2.8 million in 2017 frame the typical range for Non-Current Deffered Revenue.
• The widest YoY moves for Non-Current Deffered Revenue: up 28.44% in 2017, down 34.68% in 2017.
• Tracing RKDA's Non-Current Deffered Revenue over 4 years: stood at $3.6 million in 2014, then decreased by 27.48% to $2.6 million in 2015, then advanced by 18.32% to $3.1 million in 2016, then tumbled by 34.68% to $2.0 million in 2017.
• The last three Non-Current Deffered Revenue figures came in at $2.0 million (Q4 2017), $2.8 million (Q3 2017), and $2.9 million (Q2 2017), per Business Quant data.